Criteria, prevalence, and phenotypes of polycystic ovary syndrome.
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R.
Fertil Steril. 2016 Jul;106(1):6-15. doi: 10.1016/j.fertnstert.2016.05.003. Epub 2016 May 24.
Polycystic Ovary Syndrome.
Meier RK.
Nurs Clin North Am. 2018 Sep;53(3):407-420. doi: 10.1016/j.cnur.2018.04.008. Epub 2018 Jul 11.
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R.
Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25.
CLINICAL PRACTICE. Polycystic Ovary Syndrome.
McCartney CR, Marshall JC.
N Engl J Med. 2016 Jul 7;375(1):54-64. doi: 10.1056/NEJMcp1514916.
Criteria, phenotypes and prevalence of polycystic ovary syndrome.
Belenkaia LV, Lazareva LM, Walker W, Lizneva DV, Suturina LV.
Minerva Ginecol. 2019 Jun;71(3):211-223. doi: 10.23736/S0026-4784.19.04404-6.
Adolescent Polycystic Ovary Syndrome: An Update.
DiVall S, Merjaneh L.
Pediatr Ann. 2019 Aug 1;48(8):e304-e310. doi: 10.3928/19382359-20190729-01.
Insulin and the polycystic ovary syndrome.
Macut D, Bjekić-Macut J, Rahelić D, Doknić M.
Diabetes Res Clin Pract. 2017 Aug;130:163-170. doi: 10.1016/j.diabres.2017.06.011. Epub 2017 Jun 12.
Polycystic ovary syndrome: current status and future perspective.
Barthelmess EK, Naz RK.
Front Biosci (Elite Ed). 2014 Jan 1;6(1):104-19. doi: 10.2741/e695.
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society.
J Clin Endocrinol Metab. 2013 Dec;98(12):4565-92. doi: 10.1210/jc.2013-2350. Epub 2013 Oct 22.
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
Diamanti-Kandarakis E, Dunaif A.
Endocr Rev. 2012 Dec;33(6):981-1030. doi: 10.1210/er.2011-1034. Epub 2012 Oct 12.
